Atossa Therapeutics, Inc.
ATOS
$0.71
-$0.01-1.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.15% | -10.84% | 11.27% | 15.25% | 9.79% |
| Total Depreciation and Amortization | -40.74% | -38.46% | -36.00% | -26.09% | 145.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.11% | 107.17% | -35.68% | -47.33% | -56.58% |
| Change in Net Operating Assets | -72.96% | -118.30% | -102.53% | -70.51% | 177.83% |
| Cash from Operations | -34.39% | -33.91% | -19.73% | -0.43% | 1.72% |
| Capital Expenditure | 15.79% | -90.00% | -10.00% | -35.71% | 13.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 15.79% | -90.00% | -10.00% | -35.71% | 99.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,008.22% | 1,008.22% | 1,600.49% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,008.22% | 387.70% | 372.93% | 349.02% | 120.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.98% | -9.09% | 5.34% | 22.53% | 17.45% |